Last10K.com

Luckwel Pharmaceuticals Inc. (LWEL) SEC Filing 8-K Material Event for the period ending Wednesday, January 13, 2021

Luckwel Pharmaceuticals Inc.

HISTORY TOOLS
CIK: 1567098 Ticker: LWEL

View differences made from one to another to evaluate Luckwel Pharmaceuticals Inc.'s financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 8-K Corporate News to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Luckwel Pharmaceuticals Inc..

Continue

Assess how Luckwel Pharmaceuticals Inc.'s management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Luckwel Pharmaceuticals Inc.'s Definitive Proxy Statement (Form DEF 14A) filed after their 2021 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors

Continue

SEC Filing Tools

Material Contracts, Statements, Certifications & more

Luckwel Pharmaceuticals Inc. provided additional information to their SEC Filing as exhibits

Exhibit 10.1: Material Contract
Ticker: LWEL
CIK: 1567098
Form Type: 8-K Corporate News
Accession Number: 0001493152-21-000914
Submitted to the SEC: Wed Jan 13 2021 8:06:21 AM EST
Accepted by the SEC: Wed Jan 13 2021
Period: Wednesday, January 13, 2021
Industry: Pharmaceutical Preparations
Events:
  1. Financial Exhibit
  2. New Agreement
  3. Unregistered Sales

External Resources:
Stock Quote
Social Media
SEC.gov

Bookmark the Permalink:
https://last10k.com/sec-filings/lwel/0001493152-21-000914.htm